ORACLE CORP ORCL-PD
NYSE · stock
4/9
Piotroski F — financial health
0.8
Altman Z″ — distress risk · distress
33.9%
Dividend payout · safe
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2026 | $67.4B | $17.1B | — | -$23.7B | $42.5B |
| 2025 | $57.4B | $12.4B | — | -$394.0M | $20.5B |
| 2024 | $53.0B | $10.5B | — | $11.8B | $9.2B |
| 2023 | $50.0B | $8.5B | — | $8.5B | $1.6B |
| 2022 | $42.4B | $6.7B | — | $5.0B | -$5.8B |
| 2021 | $40.5B | $13.7B | — | $13.8B | $6.0B |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 0.8 (distress)
- Working capital / assets 0.018
- Retained earnings / assets -0.016
- EBIT / assets 0.079
- Equity / liabilities 0.194
Source: SEC EDGAR filings · CIK 0001341439 · as of 2026-05-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.